News Archive of FiercePharma Manufacturing

ArticleAdded
FDA quality focus will definitely mean winners and losers, report says02-08-16
FDA warning to Ipca Labs shines light on rampant data falsification02-09-16
Report says CMOs without U.S. facilities risk being left out of 'hot' market 02-09-16
Dr. Reddy's grows U.S. sales even in face of FDA action02-09-16
Regulator suspends Spanish drugmaker over 'critical quality defects' 02-10-16
Qualicaps gets Latin American foothold with acquisition of Brazil's Genix02-10-16
Catalent France plant that was victim of sabotage getting back online02-10-16
Ferring adding Indian plant to its global network02-11-16
Recipharm puts up $45M to enhance track-and-trace capabilities02-11-16
Eisai doubling its Indian API to ride Japan's generic wave02-11-16
Norwich Pharma spending $26M on new equipment 04-16-15
Catalent Kentucky expansion grows to $52M04-16-15
Sanofi Pasteur U.S. operation part of dengue vaccine buildup04-16-15
Bayer to pump $100M into U.S. facility focused on hemophilia drugs04-16-15
GSK plant in Ireland making headway on reducing carbon footprint 04-16-15
FDA stepping up efforts to replenish U.S. saline solution supplies04-15-15
Walgreens CEO hints at another supply chain deal04-14-15
Actavis asks court to let it stop manufacturing older Alzheimer's treatment04-14-15
Vectura will close plant in Germany within the year04-14-15
Novo opens $100M plant in Russia04-13-15
Baxter again having to recall saline solution as shortage persists04-13-15
Merck finds buyer for 2nd Puerto Rico plant slated to close04-10-15
Report: Supply chain efficiency can boost both top- and bottom-line results04-09-15
Sanofi's vax plant in France preparing to produce 100M doses of dengue vaccine04-09-15
Cipla buying Brazilian distributor for beachhead there04-09-15
Indonesia market expanding but local producers can't keep up04-08-15
Expired Pfizer contraceptives recalled after supply chain fumble04-08-15
Chinese drugmaker to build $60M API plant 04-08-15
Hospira gets yet another warning letter, this one for Italy plant04-07-15
AMRI moves forward with plan to close Wales API plant, cut 62 jobs04-07-15
Baxter recalls more than half a million units of saline04-07-15
India's Mankind Pharma investing $16M in API plant04-07-15
North Carolina compounder is closed and its products are recalled04-06-15
UAE drug distributor building a $20M plant in Dubai04-06-15
DPx buyout of specialty API maker IRIX is a wrap04-02-15
IPCA Labs' CRO in UK adding API space04-02-15
Biocon's Syngene to build a plant in India04-02-15
Doctor to pay $2M, pleads guilty to dispensing foreign cancer drugs04-02-15
Catalent wraps another Asia-Pacific deal with Pharmapak buy04-02-15
Drug distributor goes 'Google' style with new facility04-02-15
Mylan recalling two injectable drugs made in India03-31-15
Federal authorities raid Internet pharmacy operator CanadaDrugs.com03-31-15
Europe bans Chinese API maker over contamination issues03-31-15
Roche's Genentech investing $125M in Oregon plant03-31-15
Fujifilm expands in U.S. again with deal for stem cell producer03-31-15
Sanofi vaccine plant in Canada again producing ImmuCyst bladder drug03-31-15
Merck, NewLink nab $30M from BARDA to help manufacture Ebola vax 12-23-14
Cipla Medpro gets large contract to make HIV drugs for South Africa12-23-14
India warns Egyptian companies claiming to have Sovaldi for sale12-22-14
Fujifilm becomes part of U.S. pandemic defense with deal for Kalon Biotherapeutics12-22-14
Bayer picks Cardinal Health to manufacture Xofigo in U.S. 12-22-14
Fresenius closes out recall started two years ago12-22-14
Onyx Pharmaceuticals facility evacuated but no problems found 12-18-14
FDA finds issues with Hovione plant in Portugal12-18-14
Pozen gets a second CRL as its API supplier awaits FDA reinspection12-17-14
Owners, employees of compounder NECC indicted over lethal meningitis outbreak12-17-14
Indian state to train employees to think like FDA inspectors03-26-15
San Francisco requires drugmakers to fund disposal of unused meds03-26-15
Capsugel invests $25M to feed 'appetite' for vegetarian capsules03-26-15
Tolmar adds warehouse to support new manufacturing facility03-26-15
Deal done, Sun Pharma must now fix Ranbaxy's deep problems03-26-15
FDA bans 2 more IPCA plants03-26-15
Strides gets OK to buy Shasun, expand its manufacturing03-24-15
India to invest in infrastructure that drugmakers can share 03-24-15
Ban on Aarti plants follows FDA warnings 03-24-15
Norway's Weifa bets growth on separate API biz 03-24-15
Cypriot company targets Vietnam for generic expansion03-23-15
Deals for Actavis, Teva plants put G&W in the spotlight; CEO says its culture is its beacon03-23-15
Chinese company balks on reopening Boehringer plant 03-23-15
India's Micro Labs recalls drugs made at banned plant03-19-15
Wockhardt says FDA impressed by the strides it made at a banned plant03-18-15
Kite Pharma adds manufacturing assets with T-Cell Factory acquisition03-19-15
Puerto Rico manufacturing base to grow with AbbVie expansion03-19-15
Lawsuit would force FDA to ban or label wheat gluten as ingredient03-19-15
Malaysia's CCM Duopharma Biotech adds plants to compete better03-17-15
Actavis becomes Allergan and looks to manufacturing for cutting costs03-17-15
U.S. sterile manufacturer racks up 13 observations in FDA visit03-17-15
New York set to get another drug manufacturing project03-17-15
WuXi to bulk up cell therapy manufacturing in Philadelphia03-17-15
Florida CDMO gets taxpayer boost for expansion, 100 jobs 03-16-15
Hikma profits soften as shortages of doxycycline are resolved03-12-15
Mylan recalls drug after problem uncovered with Indian supplier03-12-15
GAO report blames DEA for many drug shortages03-12-15
Pfizer makes it official, it has reversed its decision to close Irish Lipitor plant03-11-15
Texas compounder corralled by federal injunction03-11-15
Manufacturing mess at J&J consumer plant results in guilty plea, $20M fine 03-11-15
FDA spanks second Novacyl Asian API plant with warning letter03-10-15
Sun's buyout of Ranbaxy gets India's approval03-10-15
Patheon strikes again; deal for Agere its second in a week03-09-15
Hospira recalls more saline as well as drug used during pregnancy03-09-15
Merck KGaA's ?50M investment in Italy will help it fill biologics demand05-20-14
FDA warning letter says Sun Pharma plant hid batch failures 05-20-14
FDA balks at accepting all EU plant inspections05-20-14
Manufacturing continues to boost WuXi PharmaTech sales05-20-14
Abbott expands manufacturing in Latin America with CFR deal05-20-14
Novasep gets FDA OK for HPAPI expansion in France05-19-14
Roche investments for boosting manufacturing now exceed $1B05-19-14
FDA sends marshals in to seize drugs from unit of Alkem05-19-14
The man behind Daiichi Sankyo buyout of Ranbaxy gives up chairman's role 05-15-14
Poor contract manufacturing sales put a big hurt on Dr. Reddy's 05-15-14
Daiichi Sankyo turns over domestic logistics to Yasuda Warehouse05-15-14
Wockhardt recalling 110,000 bottles of generic Toprol XL05-15-14
Hospira says it can prevent shortage after Canada closes Biolyse plant05-15-14
Couple who ran wholesaling scam plead guilty05-14-14
UPDATED: Merck sells Colorado biologics plant to KBI05-13-14
CSL opens $250M plant for hemophilia treatments 05-13-14
Lilly, Dobfar nailed with $450M fine, judge orders Brazilian plant closed 05-13-14
Canada regulators stop production at Biolyse Pharma in Ontario 05-12-14
WuXi says it intends to triple capacity at China plant05-12-14
Costs from FDA actions undermine Ranbaxy's earnings05-09-14
China eases price controls over concerns of shortages05-08-14
B. Braun extends recall of saline solution 05-08-14
FDA to start dumping low-value drugs refused entry to the U.S.05-08-14
NECC owners agree to pay meningitis victims $70M, insurers kick in $25M05-08-14
FDA study of generic equivalency includes drug made at banned Wockhardt plant05-08-14
India pharma industry moves to restore its fallen reputation, flagging exports05-07-14
Drug Controller General of India hosts quality workshop with FDA05-06-14
Sanofi's Shantha Biotechnics gets manufacturing issues resolved05-06-14
Italian mafia at center of network that stole vials of Roche's Herceptin05-06-14
FDA smacks Mexican facility that makes scorpion antivenom for U.S.05-06-14
Caraco plant in Detroit being shut down by Sun Pharma 05-05-14
Teva whacking 11 plants for sure, another 16 being evaluated05-05-14
Pfizer opens new $30 million operation in Ireland05-01-14
New York men indicted for selling counterfeit and unapproved drugs in U.S. 05-01-14
Hospira makes progress on plant problems, reports improved financials 05-01-14
WuXi PharmaTech expands cell therapy manufacturing in U.S. 05-01-14
Boehringer Ingelheim works a deal with Saudi firms to package its products05-01-14
Taro expands Canada plant with help from Ontario 05-01-14
Sanofi supply-chain issues again put hurt on its earnings04-29-14
Baxter adds saline production from Spain to U.S. supply 04-29-14
Takeda snags another big subsidy for influenza vaccine plant in Japan04-28-14
FDA loses another top dog in quality to Mylan 04-28-14
Pfizer opens new $30 million operation in Ireland05-01-14
New York men indicted for selling counterfeit and unapproved drugs in U.S. 05-01-14
Hospira makes progress on plant problems, reports improved financials 05-01-14
WuXi PharmaTech expands cell therapy manufacturing in U.S. 05-01-14
Boehringer Ingelheim works a deal with Saudi firms to package its products05-01-14
Taro expands Canada plant with help from Ontario 05-01-14
Sanofi supply-chain issues again put hurt on its earnings04-29-14
Baxter adds saline production from Spain to U.S. supply 04-29-14
Takeda snags another big subsidy for influenza vaccine plant in Japan04-28-14
Indian ban on Wockhardt plant lifted by top Indian regulator04-28-14
Bloomberg: Sun Pharma plant employees faked test results 04-25-14
FDA loses another top dog in quality to Mylan 04-28-14
Regulatory issues crush India's drug export growth04-24-14
FDA is now reporting recalls still awaiting classification 04-24-14
China's Sinovac gets $9.6M grant to build vaccine plant 04-24-14
Report: Industry's regulatory-centric focus for manufacturing will no longer cut it 04-24-14
Bristol-Myers extends manufacturing pact with Samsung04-24-14
Wockhardt smacked by state regulator in India 04-23-14
Novartis close on deal to sell contract patchmaker LTS Lohmann 04-22-14
Novartis deals with GSK and Lilly switch up manufacturing landscape 04-22-14
Cubist again recalls some Cubicin tied to contractor problem04-21-14
FDA issued import alert after importer tried to ship saline not approved in U.S.04-22-14
GSK plans to unload site of closed Indian API plant04-21-14
Hospira recalls 7 lots of propofol and one of lidocaine04-21-14
Novartis' Sandoz unit recalls some Ritalin over packaging issue04-17-14
NeoStem adds cell therapy manufacturing capacity with CSC buyout04-17-14
UPDATED: Bill for California statewide disposal law lands in the trash 04-17-14
Counterfeits of Roche's Herceptin found in EU supply chain 04-17-14
Novartis' Alcon opens $160M plant in Singapore04-17-14
U.K. starts work on $64M biologics manufacturing center04-17-14
FDA bans Baxter plant that makes saline solution 04-15-14
Impax believes manufacturing issues are fixed 04-15-14
Lupin recalls more Suprax04-14-14
Plant that Patheon wanted to sell gets $300M investment 04-14-14
FDA tags yet another Indian drugmaker, Canton Labs, with ban04-14-14
Teva recalling more than 1M bottles of generic Cymbalta04-14-14
ViiV recalls 1,000 bottles of Tivicay for cross-contamination04-14-14
Novartis' government-backed vaccine plant should be operational by 201704-10-14
AbbVie partners with Arabio for production in Saudi Arabia04-10-14
Sources: Sun has blueprint for turning Ranbaxy around 04-10-14
Kyowa Hakko Kirin finishes $60M biologics API plant 04-09-14
Neuland opens API plant as part of its partnership with Mitsubishi04-09-14
Indian authority withdraws Ranbaxy plant export permit04-09-14
GSK logistics program improves on-time delivery to 90%04-08-14
China's WuXi invests in edible anti-counterfeiting tech 04-08-14
FDA is adding inspectors in China but for now it has only 2 04-08-14
Lilly well-positioned with track-and-trace deadlines advancing04-08-14
UPM putting plant it bought from Pfizer to more use 04-07-14
Daiichi Sankyo sells off Ranbaxy's problems to Sun Pharma04-07-14
Aurobindo gets control of 7 Actavis API plants in Europe04-03-14
Merck puts big data to work to solve vaccine manufacturing concern 04-03-14
Alexion says it will add third operation in Ireland 04-03-14
Hikma earns FDA closeout letter for its New Jersey plant 04-02-14
Apotex plant in India tagged with import ban04-02-14
GSK recalls Paxil after FDA issues warning letter04-02-14
Bayer will spend $138M to expand its Beijing plant 04-01-14
Regeneron resolves objections to its new Ireland plant 04-01-14
GSK sells Indonesia plant even as it boosts commitment there 03-31-14
Hospira settles investor suit tied to its manufacturing mess-ups03-31-14
FDA lets Fresenius import saline to help with shortage03-31-14
GSK commits $165M toward 5 more plants in Africa03-31-14
French CMO Novacep sees growth03-27-14
FDA takes aim at yet another Indian API maker 03-27-14
FDA's Woodcock throws cold water on generic drug research03-27-14
Market force may put quality at forefront of all generic makers 03-27-14
GSK says someone tampered with alli bottles03-26-14
Baxter, FDA scramble to overcome shortage of nitroglycerin03-26-14
AmerisourceBergen expands in Brazil with $100M deal 03-25-14
Hospira CEO gets nearly $10 million for steering drugmaker through issues03-25-14
FDA approves J&J to make bulk Doxil at closed Ben Venue plant03-25-14
AMRI ratchets manufacturing up further with Cedarburg buyout03-25-14
GSK adopts Formula One racing mentality to speed Breo inhaler production03-24-14
India cracks down on same Wockhardt plants FDA has banned 03-24-14
Novartis CEO predicts generic industry fallout as quality takes center stage03-20-14
OTC maker has discovery published in New England Journal of Medicine 03-20-14
Indian regulator finds number of substandard drugs on the rise03-20-14
Parexel opens Singapore distribution facility 03-20-14
FDA cuts U.S. plant inspections while boosting them overseas03-20-14
FDA jumps compounder for making unapproved domperidone03-19-14
Novo Nordisk looks at turning its IT services into its own biz03-18-14
Indian drugmakers ponder opening plants in U.S., Europe 03-18-14
Olympus to close U.S. biologics plant and lay off 13003-18-14
Sagent looks to expand its China plant and to add proprietary products03-17-14
Shire lays blame for Vpriv recall at feet of contractor03-17-14
Novo building $100M plant in Denmark in big R&D push03-15-14
Hikma hits the jackpot with doxycycline shortage03-13-14
Pharma cargo theft takes new spike 03-13-14
Sun Pharma plant joins the FDA list of banned Indian facilities03-13-14
CMO born from $2.6 billion merger comes on the scene as DPx 03-13-14
FDA says Indian drugmaker made up data for API tests03-12-14
Bayer expands German plants as it preps for new hemophilia treatments03-12-14
Pfizer is expanding its plant in Indonesia--again03-11-14
Global rise in pain drug use puts the hurt on Tasmania's poppy production 03-11-14
Source: Ranbaxy shops for Nexium API to salvage lucrative launch03-11-14
BMS joins Merck with plans to whack plants in Ireland03-10-14
Ranbaxy recalls generic Lipitor after druggist finds 20-mg dose in 10-mg bottle 03-10-14
Pfizer recalls bottles of antidepressant that might have a heart drug mixed in 03-10-14
Bloomberg: Worker safety also an issue with Ranbaxy plant03-06-14
GSK shares grant to help U.K. on how to rebuild its drug manufacturing base03-06-14
Lilly and its partner Novast start work on a plant in China03-06-14
Sagent recalls drug because of leaking bags03-05-14
Plant issues cost Lilly, Boehringer Ingelheim a drug approval03-05-14
Baxter recalls a dialysis product due to mold 03-05-14
Regeneron preparing for a plant expansion and a fill-finish facility in Ireland03-04-14
Pharma packaging market is forecast to hit $90 billion in 201703-04-14
Lilly invests in its Brazilian packaging plant 03-04-14
Drug purchasing group wants drugmakers to work with GPOs on shortages03-03-14
Fresenius to build new plant in Australia 03-03-14
Jubilant says the FDA has cleared its Canada plant 03-03-14
AstraZeneca's Delaware campus sold to JPMorgan 02-27-14
Pfizer gets past shortage of hypothyroid drug Levoxyl02-27-14
Mylan earnings point to reason for Agila deal 02-27-14
Bayer expands production in China by bagging Dihon 02-27-14
Critics call for harsher treatment of foreign drugmakers who sell faulty drugs02-27-14
Doc goes to jail for lying about foreign-sourced Botox02-27-14
Pfizer and MIT are looking for more efficient biologics manufacturing02-25-14
The FDA catches another Indian drugmaker falsifying data02-25-14
Ranbaxy halts production at 2 plants to tackle its regulatory mess02-25-14
The FDA has expanded its equivalency testing of generics02-24-14
GSK vows to maintain soccer fields in new U.K. plant02-24-14
Hamburg says FDA's focus on India reflects its place in the global supply chain 02-24-14
India pressures Merck and GSK on vaccine prices 02-20-14
West Pharmaceutical benefits from emerging market growth02-20-14
GSK plant goes more than three years without plant injury02-20-14
Excipient makers jump on audits as new regs kick in02-20-14
Cold-chain costs were halved in African vaccine campaign 02-20-14
13 drugmakers picked for FDA's special import perks 02-20-14
Amgen responds to FDA warning letter over drug/device combos02-18-14
FDA's Hamburg comes back from India with high hopes about quality standards02-18-14
Shire gets FDA nod for a second U.S. plant to make Vpriv02-18-14
Ben Venue Labs may be closed but it is still recalling products02-18-14
Hikma's remediation costs have been offset by doxycycline sales02-15-14
Mylan recalls injectable drugs after pieces of label found in some vials02-14-14
Congress wants more info about the quality of foreign-made generics02-13-14
New plants in Middle East a testament to the region's emerging market status02-13-14
Catalent to expand in U.S. and add 230 jobs to its Kansas City operation 02-13-14
Irish Regeneron plant to produce tax benefits as well as drugs02-12-14
The FDA slams a Hong Kong API distributor for the sorry state of its quality controls02-12-14
2 Hospira plants improve their FDA standing as improvements kick in02-12-14
Perrigo sees growth, but its sales are trimmed by a hit to contract manufacturing02-11-14
Novartis is expanding a plant in Singapore02-11-14
FDA says products recalled by compounder are contaminated02-11-14
FDA reports far fewer new drug shortages, but the problem continues to grow02-11-14
Wockhardt's earnings crash under the weight of FDA bans02-10-14
Jazz investing up to $68M to build its first manufacturing facility02-10-14
Teva, which has been tightening its supply chain, turns in a surprising financial report02-06-14
7 Ohio docs pony up $2.6M for buying foreign-made cancer drugs02-06-14
AbbVie picks Singapore for a $320M production facility02-06-14
BMS plots major job cuts at plants in France02-06-14
As Ranbaxy's plant problems mount, so do its losses02-06-14
FDA Commissioner Hamburg heads for India to talk about quality manufacturing02-05-14
Sources: Recipharm looks at doing an IPO to expand cash02-04-14
Lupin stakes a claim on the sterile injectables market02-04-14
Alexion buys vial-filling facility in Ireland 02-04-14
Abbott closing plant in Puerto Rico as Mexico's Neolpharma expands02-03-14
Amgen halting Epogen manufacturing in Colorado02-03-14
Daiichi Sankyo bringing hammer down on Ranbaxy02-03-14
Flu hospitalizations are putting pressure on saline manufacturers in face of a shortage01-30-14
Cytovance expands its biologics manufacturing and warehousing operations01-30-14
Amgen confirms the $1B Ireland plant it postponed 7 years ago will not get built01-30-14
DOJ says to expect consent decrees like the one Ranbaxy signed as its tool of choice 01-30-14
India's top drug regulator says he will do surprise inspections of foreign-owned plants01-29-14
Novartis' production reduction plan has shed 20 plants in 4 years 01-29-14
NextSource brings back Lomustine, the brain cancer drug that BMS stopped making 01-28-14
India has different attitudes about the standards at facilities targeted by the FDA01-28-14
GSK blames chickenpox vaccine shortage on plant problems 01-28-14
Ranbaxy's repeat violation elicits swift FDA action01-27-14
Actavis selling China plant as it unloads manufacturing capacity globally01-27-14
Feds nab two men from Turkey in effort to counter counterfeits 01-27-14
Lonza's pharma unit sales suffer as it closes U.S. biologics plant 01-23-14
Lilly gets ready for track-and-trace in U.S.01-23-14
Glaxo investing $200M in additions to U.K. site01-23-14
New York plant that makes Diovan is next on Novartis' shutdown list01-23-14
Par bolsters its sterile manufacturing with $490M deal to grab JHP01-23-14
J&J consumer health boosts results, even without key plant 01-22-14
Novartis manufacturing gets more jobs in major restructuring01-21-14
Saline shortage: FDA works with Baxter, Hospira and Braun01-21-14
FDA recall questions the sterility of eye drops made in Vietnam01-21-14
Aurobindo deal with Actavis accelerates its expansion of sterile injectables biz01-21-14
Shire has a partially built plant for sale after unloading Dermagraft 01-20-14
UPDATED: Genentech resolves plant back-up quickly but timing was bad01-17-14
Actavis selling China assets as it exits that country01-16-14
Sources: Ranbaxy asks the FDA to let it make generic Diovan in U.S. 01-16-14
FDA assigns an agent to Europol in its fight against fakes01-16-14
Premier supports new FDA compounder oversight plan01-16-14
Ex Fresenius employee says he was fired for raising red flags 01-15-14
Merck recalls all lots of Liptruzet shipped since its May debut01-14-14
McKesson recalibrates its EU strategy after Celesio deal nosedives01-14-14
Wockhardt hires a new compliance exec in the face of FDA bans01-14-14
Ranbaxy manufacturing drama continues with FDA action on API plant01-14-14
China corruption probe takes a turn into domestic drug distribution business 01-13-14
Aurobindo looking to buy API plants from Actavis 01-13-14
11 compounders tell the FDA to bring it on01-10-14
Rumored Novartis, Merck asset swap has interesting manufacturing implications01-09-14
Amgen facility has its 2nd explosion in 9 months01-09-14
Patheon deal for DSM would transform it into second-largest CMO in the world01-09-14
UPDATED: Roche's Genentech tells FDA to expect brief Tamiflu shortage01-08-14
FDA names Sklamberg to oversee global regulatory issues01-08-14
McKesson trying to appease hedge fund on Celesio buyout01-08-14
Baxter issues another recall after particulate found in products 01-07-14
EMA makes inspection reports public 01-07-14
China clears vaccine-makers in deaths then shuts some down01-07-14
Chinese heparin maker Hepalink buying U.S.-based SPL 01-07-14
Pall moves into singe-use bioreactors with deal to buy ATMI LifeSciences01-06-14
$1B deal pushes GE further into biologics manufacturing01-06-14
$100M fund outlined for victims of NECC manufacturing problems01-02-14
Transfer of GSK plant to Aspen Pharmacare will wait until midyear 01-02-14
Baxter initiates a 4-country recall after particulate is found in solutions01-02-14
China takes aim at poor-quality drug production01-02-14
Hospira's India plant disappoints the FDA again12-30-13
J&J moves forward with its plan to make Doxil in part of the closed Ben Venue plant 12-30-13
FDA puts veterinary drugs from banned Wockhardt plants on a leash12-19-13
CEO Nakayama says Daiichi Sankyo is helping Ranbaxy deal with the FDA's concerns12-19-13
AstraZeneca will take over 2 U.S. plants in its $4.1B diabetes drug transfer 12-19-13
The FDA and EU members will share some inspection duties12-19-13
Novartis to shed Alcon plant, 300 jobs next year12-17-13
Wales fines companies 120,000 for worker accidents 12-17-13
UPDATED: Teva reneges on its proposal to build a $141M API plant in India12-17-13
What's a makeover cost these days? For AstraZeneca's distribution hub, $100M 12-17-13
The FDA and EU members will share some inspection duties12-19-13
Regeneron will invest $300M, hire 300 in its revamp of a Dell plant in Ireland12-18-13
Hacked off: Congress members, PhRMA urge an outside audit of the FDA data breach12-18-13
FDA puts veterinary drugs from banned Wockhardt plants on a leash12-19-13
CEO Nakayama says Daiichi Sankyo is helping Ranbaxy deal with the FDA's concerns12-19-13
AstraZeneca will take over 2 U.S. plants in its $4.1B diabetes drug transfer 12-19-13
FDA warns NJ lotion maker: Your water does not meet specs12-12-13
ScinoPharma's $113 million China API plant ready to go12-12-13
Merck KGaA building ?40 million plant in Germany12-12-13
FDA stationing 10 new drug inspectors in China 12-12-13
GSK's new manufacturing investments in the U.K. now pass $1 billion 12-11-13
Cardinal, CVS JV creates more upheaval in U.S. drug supply chain 12-10-13
Feds close down importer that sold unapproved Botox and cancer drugs12-10-13
Pharma Tech adds capacity as the CMO industry heats up12-10-13
Hospira cuts costs by expanding drug and API production outside of the U.S. 12-10-13
Track-and-trace is here ... and now 12-06-13
Biogen API plant gets nicked by the FDA 12-09-13
Alvogen makes a $250M biosimilars investment in Iceland 12-09-13
FDA spanks a second Jubilant HollisterStier plant12-09-13
Patheon invests in U.K. plant, posts operating loss12-05-13
PhRMA begins another lawsuit against a drug-disposal law12-05-13
Boehringer taps BofA to talk up potential of sterile injectables plant12-05-13
Pfizer whacking 150 jobs in closure of Irish packaging plant12-05-13
FDA warning letter tasks Wockhardt with global plant assessment12-04-13
In cancer immunotherapy joint venture, Fred Hutch and MSKCC face manufacturing challenges12-04-13
Hedge fund ups the ante in game of chicken with McKesson12-03-13
FDA outlines plans for new compounding pharmacy powers12-03-13
India drops plans to limit foreign ownership of production capacity12-03-13
Gland Pharma targets U.S. injectables sector after securing $200M12-03-13
Wockhardt braces for lost sales after FDA bans its main plant12-03-13
Irish plant shutdown puts another Merck site on the block12-01-13
Ranbaxy ready to bail on vaccine manufacturing11-26-13
Bafna draws buyout interest for its European-approved manufacturing 11-26-13
Skin patch manufacturer could sell for $1.6 billion 11-26-13
PL Developments, Aaron combine expertise in OTC manufacturing11-26-13
Glaxo piles onto API expansion in Scotland11-26-13
JLL expects to buy more CMOs11-25-13
Indian CMOs squeezed by exchange rates, price pressures11-21-13
JLL lines up financing for $2.6B Patheon, DSM deal11-21-13
GE Oslo plant gets FDA OK for new heart imaging product11-21-13
Pfizer to close Puerto Rico plant11-21-13
Unilife grabs $40M contract to fill Hikma injectables11-20-13
Actavis puts California plant on hit list11-20-13
Mylan recalls 480,000 bottles of blood pressure med 11-19-13
U.S. approves drug tracking, compound pharmacy oversight law11-19-13
DSM, Patheon join up in $2.6B deal11-19-13
J&J, Merck KGaA roll out new China plant projects11-19-13
2 Puerto Rico plants up next in Merck job-whacking plan11-19-13
Glaxo to use new technology in India plant11-18-13
New manufacturing processes could produce bird flu vax ASAP 11-14-13
Track-and-trace bill may be finished this week11-14-13
Lilly announces $700M in plant expansions11-14-13
Sandoz pulls some TB drugs in India11-14-13
Dendreon hopes manufacturing can save the day11-13-13
FDA red-flags dangerous counterfeit ED product 11-13-13
More than 27M pharma units recalled in Q311-12-13
Alexion recalls more Soliris11-12-13
Daiichi Sankyo says it was burned in Ranbaxy buyout11-12-13
J&J, Amazon fight shows supply-chain weakness in online sales11-11-13
Actavis to close NC plant, trim 310 jobs11-11-13
AstraZeneca stays in England with $190 million plant11-11-13
Hospira CEO looks to better days as 'swamp draining' nears end11-07-13
Nosco hiring 51 staff for packaging and labeling plant11-07-13
Wholesaler McKesson settles another price-manipulation suit11-07-13
FDA finally lifts warning letter on AMRI fill/finish facility11-07-13
Visa woes still stalling FDA plans for China inspections11-06-13
Pfizer contractors testing new methods to clean up old production site11-06-13
FDA outlines plan to incentivize high-quality manufacturing11-05-13
Novartis puts OTC unit and its troubled plant on second tier of sale priorities11-05-13
Stalling biosimilars give Roche confidence to reopen Genentech plant11-05-13
Developer pitches plan for Boston R&D and manufacturing complex11-05-13
PwC warns quality failings could slow growth of Indian biopharma 11-04-13
Merck to give pink slips to 500 West Point workers this holiday season11-04-13
WuXi adds two 2000-L bioreactors to Shanghai facility10-31-13
Foreign cancer-drug dealer gets prison10-31-13
DSM opens Australia biologics plant 10-30-13
Space issues lead GSK to close NJ facility, shift production10-30-13
India renews duty on Chinese paracetamol10-30-13
Toronto plant problems shoot holes in Sanofi earnings10-30-13
Sun's Caraco plants address FDA issues 10-29-13
Ranbaxy profits hit hard as FDA ban starts to sting10-29-13
Mylan completes small India deal ahead of Agila buyout10-29-13
Wockhardt profits crater after U.S, U.K. plant bans10-29-13
Gilead expanding facility that makes anticipated hep C drug10-28-13
Manufacturing glitch leaves Novo insulin cartridges with bad fills 10-28-13
India's plan to inspect China plants stalled 10-28-13
Drugmakers renew attack on takeback law10-24-13
Stolen Novo growth hormone sold on Internet10-24-13
McKesson makes $8.3B move on Europe 10-24-13
Hospira unveils new quality lab at troubled plant10-23-13
Actis invests $48M in API maker Symbiotec10-23-13
Samsung will make some Roche biologics 10-23-13
German contract manufacturers invest ?70 million on expansions 10-22-13
Authorities seize large load of fake Xanax headed for Egypt10-22-13
U.K. takes enforcement action against third Wockhardt plant 10-22-13
Biocad taking biosimilar production to Brazil 10-22-13
Teva opens $100M Croatia plant as it cuts elsewhere10-22-13
Teva API plant workers strike over wage gaps10-21-13
Aesica looks to Japan, hooks up with CDMO there 10-17-13
In turnabout, U.K. tells Wockhardt to recall 5 drugs 10-17-13
Teva reconsiders production cuts in Israel10-17-13
Federal case over drug shortage comes to an end10-17-13
B. Braun recalls product after organic particulate found10-17-13
Genzyme expanding U.S. plant opened last year10-16-13
U.S. awards special status to fired Novartis workers 10-15-13
Israeli unions threaten strikes over Teva job cuts10-15-13
FDA closes out inspection on Ranbaxy New Jersey plant 10-15-13
SAFC adds biologics capabilities at 2 plants10-14-13
Wockhardt problems pile up; U.K. bans second plant10-14-13
Roche expanding biologics production in 3 countries10-14-13
BioCentury finds FDA has $270M in GDUFA, PDUFA fees in hand10-10-13
Catalent moves on Brazil VMS, softgel market 10-10-13
Teva looks for big savings from procurement, manufacturing 10-10-13
McKesson may follow AmerisourceBergen into EU10-09-13
Vetter putting $100M into its production network10-09-13
Feds fight drug imports Maine now allows10-09-13
FDA cites labs that tested tainted drugs10-08-13
Ranbaxy may look to buy FDA-approved plant in India10-08-13
Recipharm, Fujifilm expand their biologics capabilities 10-08-13
Sartorius picking up TAP Biosystems in $45M deal10-07-13
Boehringer Ingelheim plant has become a money pit10-07-13
Aesica fined $161,000 for worker injury10-07-13
Some companies now tout passing plant inspection10-03-13
Ranbaxy denies FDA issues will lead to layoffs10-03-13
SCM offers 'blank canvas' to sterile injectable clients10-03-13
FDA threatens drugmaker with ban for not paying user fee10-03-13
CML, AAIPharma join forces to create CMC specialist10-03-13
Hospira reports more vial problems 10-02-13
10-year timeline set for unit-level drug tracking 10-01-13
FDA plant inspections continue, even in government chaos10-01-13
Merck joins Bahrain venture10-01-13
Legislation defines when FDA can take action against compounders10-01-13
GSK opens $40M plant in Cork, Ireland, adding 20 jobs09-30-13
Boehringer Ingelheim Shanghai plant tripling capacity 09-30-13
Pfizer dumping plant, 140 workers in Australia09-26-13
Sanofi building its largest African plant in Algeria 09-26-13
Purdue building $59M plant in North Carolina09-26-13
J&J says more Doxil shortages imminent, tied to Ben Venue problems09-26-13
FDA warning points to infrastructure issue in India09-25-13
Kashmir-born Ph.D. takes on India's stumbling industry for FDA 09-25-13
Another Fresenius plant gets warning letter 09-25-13
FDA warns Agila plant over torn gloves09-24-13
Pharma squares off against compounders in lobbying fight09-24-13
J&J wins a bright spot after string of recalls09-24-13
FDA beefs up Indian staff in face of serious problems09-24-13
U.K., Australia gather FDA intel on Ranbaxy ban09-23-13
Bristol-Myers, AstraZeneca recall 92K vials of Bydureon from EU09-23-13
Vietnam attracts some drug production despite challenges09-19-13
MIT works on process to manufacture biologics in 24 hours09-19-13